无症状性高尿酸血症：或许并非那么良性？ - Suppr

Suppr

超能文献

Asymptomatic hyperuricemia: perhaps not so benign?

作者信息

Neogi Tuhina

出版信息

J Rheumatol. 2008 May;35(5):734-7.

PMID:18464314

Abstract

摘要

相似文献

Asymptomatic hyperuricemia: perhaps not so benign?

J Rheumatol. 2008 May;35(5):734-7.

Medical implications of hyperuricemia.

Med Health R I. 2009 Nov;92(11):353-5.

Comment on: Gout: an independent risk factor for all-cause and cardiovascular mortality.

Rheumatology (Oxford). 2010 Jul;49(7):1421-2; author reply 1422. doi: 10.1093/rheumatology/keq118. Epub 2010 Apr 27.

Advanced kidney failure and hyperuricemia.

Adv Chronic Kidney Dis. 2012 Nov;19(6):419-24. doi: 10.1053/j.ackd.2012.07.008.

Hyperuricemia and associated diseases.

Rheum Dis Clin North Am. 2006 May;32(2):275-93, v-vi. doi: 10.1016/j.rdc.2006.02.005.

Altered uric acid levels and disease states.

J Pharmacol Exp Ther. 2008 Jan;324(1):1-7. doi: 10.1124/jpet.107.129031. Epub 2007 Sep 21.

[HYPERURICEMIA AND POTENTIAL RISK OF CARDIOVASCULAR AND RENAL DISEASES].

Rev Med Liege. 2016 May;71(5):262-8.

Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk.

Am J Cardiol. 2009 Mar 15;103(6):867-71. doi: 10.1016/j.amjcard.2008.11.042. Epub 2009 Jan 24.

Genetic factors associated with gout and hyperuricemia.

Adv Chronic Kidney Dis. 2006 Apr;13(2):124-30. doi: 10.1053/j.ackd.2006.01.008.

Understanding treatments for gout.

Am J Manag Care. 2005 Nov;11(15 Suppl):S451-8; quiz S465-8.

引用本文的文献

In Vivo Effects of Orally Administered Different Concentrations of Silver Oxide Nanoparticles in Hyperuricemic Mice.

Biol Trace Elem Res. 2022 Aug;200(8):3677-3687. doi: 10.1007/s12011-021-02960-3. Epub 2021 Oct 31.

Cost Comparison of Urate-Lowering Therapies in Patients with Gout and Moderate-to-Severe Chronic Kidney Disease.

J Manag Care Spec Pharm. 2016 Apr;22(4):326-36. doi: 10.18553/jmcp.2016.22.4.326.

Characteristics of the first metatarsophalangeal joint in gout and asymptomatic hyperuricaemia: a cross-sectional observational study.

J Foot Ankle Res. 2015 Aug 18;8:41. doi: 10.1186/s13047-015-0091-8. eCollection 2015.

The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia.

J Res Med Sci. 2012 Nov;17(11):1039-46.

Uric acid and the origins of hypertension.

J Pediatr. 2013 May;162(5):896-902. doi: 10.1016/j.jpeds.2012.12.078. Epub 2013 Feb 10.

Hyperuricemia in obese children and adolescents: the relationship with metabolic syndrome.

Pediatr Rep. 2010 Jun 18;2(1):e12. doi: 10.4081/pr.2010.e12.

Joint and tendon subclinical involvement suggestive of gouty arthritis in asymptomatic hyperuricemia: an ultrasound controlled study.

Arthritis Res Ther. 2011 Jan 17;13(1):R4. doi: 10.1186/ar3223.

Update on biology: uric acid and the activation of immune and inflammatory cells.

Curr Rheumatol Rep. 2010 Apr;12(2):135-41. doi: 10.1007/s11926-010-0092-3.

Hyperuricemia and coronary heart disease: a systematic review and meta-analysis.

Arthritis Care Res (Hoboken). 2010 Feb;62(2):170-80. doi: 10.1002/acr.20065.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Asymptomatic hyperuricemia: perhaps not so benign?

J Rheumatol. 2008 May;35(5):734-7.

Medical implications of hyperuricemia.

Med Health R I. 2009 Nov;92(11):353-5.

Comment on: Gout: an independent risk factor for all-cause and cardiovascular mortality.

Rheumatology (Oxford). 2010 Jul;49(7):1421-2; author reply 1422. doi: 10.1093/rheumatology/keq118. Epub 2010 Apr 27.

Advanced kidney failure and hyperuricemia.

Adv Chronic Kidney Dis. 2012 Nov;19(6):419-24. doi: 10.1053/j.ackd.2012.07.008.

Hyperuricemia and associated diseases.

Rheum Dis Clin North Am. 2006 May;32(2):275-93, v-vi. doi: 10.1016/j.rdc.2006.02.005.

Altered uric acid levels and disease states.

J Pharmacol Exp Ther. 2008 Jan;324(1):1-7. doi: 10.1124/jpet.107.129031. Epub 2007 Sep 21.

[HYPERURICEMIA AND POTENTIAL RISK OF CARDIOVASCULAR AND RENAL DISEASES].

Rev Med Liege. 2016 May;71(5):262-8.

Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk.

Am J Cardiol. 2009 Mar 15;103(6):867-71. doi: 10.1016/j.amjcard.2008.11.042. Epub 2009 Jan 24.

Genetic factors associated with gout and hyperuricemia.

Adv Chronic Kidney Dis. 2006 Apr;13(2):124-30. doi: 10.1053/j.ackd.2006.01.008.

Understanding treatments for gout.

Am J Manag Care. 2005 Nov;11(15 Suppl):S451-8; quiz S465-8.

引用本文的文献

In Vivo Effects of Orally Administered Different Concentrations of Silver Oxide Nanoparticles in Hyperuricemic Mice.

Biol Trace Elem Res. 2022 Aug;200(8):3677-3687. doi: 10.1007/s12011-021-02960-3. Epub 2021 Oct 31.

Cost Comparison of Urate-Lowering Therapies in Patients with Gout and Moderate-to-Severe Chronic Kidney Disease.

J Manag Care Spec Pharm. 2016 Apr;22(4):326-36. doi: 10.18553/jmcp.2016.22.4.326.

Characteristics of the first metatarsophalangeal joint in gout and asymptomatic hyperuricaemia: a cross-sectional observational study.

J Foot Ankle Res. 2015 Aug 18;8:41. doi: 10.1186/s13047-015-0091-8. eCollection 2015.

The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia.

J Res Med Sci. 2012 Nov;17(11):1039-46.

Uric acid and the origins of hypertension.

J Pediatr. 2013 May;162(5):896-902. doi: 10.1016/j.jpeds.2012.12.078. Epub 2013 Feb 10.

Hyperuricemia in obese children and adolescents: the relationship with metabolic syndrome.

Pediatr Rep. 2010 Jun 18;2(1):e12. doi: 10.4081/pr.2010.e12.

Joint and tendon subclinical involvement suggestive of gouty arthritis in asymptomatic hyperuricemia: an ultrasound controlled study.

Arthritis Res Ther. 2011 Jan 17;13(1):R4. doi: 10.1186/ar3223.

Update on biology: uric acid and the activation of immune and inflammatory cells.

Curr Rheumatol Rep. 2010 Apr;12(2):135-41. doi: 10.1007/s11926-010-0092-3.

Hyperuricemia and coronary heart disease: a systematic review and meta-analysis.

Arthritis Care Res (Hoboken). 2010 Feb;62(2):170-80. doi: 10.1002/acr.20065.